Global Ibuprofen API Market to reach USD XX billion by 2027.Global Ibuprofen API Market is valued approximately at USD XX billion in 2020 and is anticipated to grow with a healthy growth rate of more than 4.8% over the forecast period 2021-2027. Ibuprofen is a drug that belongs to the anti-inflammatory drug class. It aids in the reduction of hormones that produce pain and inflammation in the body. Ibuprofen is used to treat fever, toothaches, back pain, headaches, and menstruation discomfort, among other problems. The medication is a propionic acid derivative that is non-steroidal. Ibuprofen market expansion is supported by an ageing population that is more susceptible to illnesses and health conditions. The market is driven by growing prevalence of chronic disorders and upsurge in pharmaceutical and biopharmaceutical production. The number of cases of rheumatoid arthritis in India has grown from 183,272 in 2007 to 263,365 in 2017, according to the Institute for Health Metrics and Evaluation. As a result, depending on the number of cases in other major Asian nations, healthcare activities related to the treatment of rheumatoid arthritis will need widespread and constant support. However, rising production costs may impede market growth over the forecast period of 2021-2027.

Asia-Pacific market is expected to develop rapidly over the projected period due to rising health spending. Furthermore, the low cost of manufacturing in China and India has led to an increase in production facilities, attracting pharmaceutical and biotechnology companies from all over the world to the Asia-Pacific region.

Major market player included in this report are:

IOL Chemicals and Pharmaceuticals Limited
BASF SE
Sino-US Zibo Xinhua-Perrigo Pharmaceutical Co., Ltd.
BIOCAUSE Inc.
Solara Active Pharma Sciences Limited
SI Group, Inc.
Perrigo Company
Alveda Pharmaceuticals
Reckitt Benckiser
Xinhua Pharmaceutical etc.




The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Application:
Headache
Arthritis
Others
By End user:
CROs and CMOs
Pharmaceutical and Biopharmaceutical Company
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019
Base year - 2020
Forecast period - 2021 to 2027.

Target Audience of the Global Ibuprofen API Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors